These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33158605)

  • 1. Is COVID-19 a Perfect Storm for Parkinson's Disease?
    Brundin P; Nath A; Beckham JD
    Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
    Conte C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience.
    Buccafusca M; Micali C; Autunno M; Versace AG; Nunnari G; Musumeci O
    Neurol Sci; 2021 Mar; 42(3):811-816. PubMed ID: 33439387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
    Follmer C
    Mov Disord; 2020 Sep; 35(9):1495-1496. PubMed ID: 32822087
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives.
    Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Ahmed EA; Batiha GE
    J Neurosci Res; 2023 Jun; 101(6):952-975. PubMed ID: 36717481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
    Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19.
    Mancini M; Natoli S; Gardoni F; Di Luca M; Pisani A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Intersection of Parkinson's Disease, Viral Infections, and COVID-19.
    Rosen B; Kurtishi A; Vazquez-Jimenez GR; Møller SG
    Mol Neurobiol; 2021 Sep; 58(9):4477-4486. PubMed ID: 34033061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Parkinsonism: A Critical Appraisal.
    Cavallieri F; Fioravanti V; Bove F; Del Prete E; Meoni S; Grisanti S; Zedde M; Pascarella R; Moro E; Valzania F
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and seizures: Is there a link?
    Vohora D; Jain S; Tripathi M; Potschka H
    Epilepsia; 2020 Sep; 61(9):1840-1853. PubMed ID: 32944929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smell deficits in COVID-19 and possible links with Parkinson's disease.
    Emmi A; Sandre M; Porzionato A; Antonini A
    Int Rev Neurobiol; 2022; 165():91-102. PubMed ID: 36208908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
    Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases.
    Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M
    Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease following COVID-19: causal link or chance occurrence?
    Li WS; Chan LL; Chao YX; Tan EK
    J Transl Med; 2020 Dec; 18(1):493. PubMed ID: 33375935
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risk and course of COVID-19 in patients with Parkinson's disease].
    Zalyalova ZA; Khasanova DM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):152-156. PubMed ID: 34693704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.
    Estrada E
    Viruses; 2021 May; 13(5):. PubMed ID: 34066091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covid-19 Infection and Parkinsonism: Is There a Link?
    Bouali-Benazzouz R; Benazzouz A
    Mov Disord; 2021 Aug; 36(8):1737-1743. PubMed ID: 34080714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of COVID-19 on Access to Parkinson's Disease Medication.
    Cheong JL; Goh ZHK; Marras C; Tanner CM; Kasten M; Noyce AJ;
    Mov Disord; 2020 Dec; 35(12):2129-2133. PubMed ID: 32860226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region.
    Del Prete E; Francesconi A; Palermo G; Mazzucchi S; Frosini D; Morganti R; Coleschi P; Raglione LM; Vanni P; Ramat S; Novelli A; Napolitano A; Battisti C; Giuntini M; Rossi C; Menichetti C; Ulivelli M; De Franco V; Rossi S; Bonuccelli U; Ceravolo R;
    J Neurol; 2021 Apr; 268(4):1179-1187. PubMed ID: 32880722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 infection may increase the risk of parkinsonism - Remember the Spanish flu?
    Eldeeb MA; Hussain FS; Siddiqi ZA
    Cytokine Growth Factor Rev; 2020 Aug; 54():6-7. PubMed ID: 32563553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.